ATI(ATI)
Search documents
ATI announces sale of precision rolled strip operations to Ulbrich
Prnewswire· 2024-11-06 21:45
Sharpens focus on strategic aerospace and defense markets, streamlines operations DALLAS, Nov. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced it completed the sale of its precision rolled strip operations in New Bedford, Massachusetts and Remscheid, Germany to Ulbrich Stainless Steels and Special Metals, Inc. (Ulbrich)."With this divestiture, ATI sharpens its focus on providing our aerospace and defense customers with the titanium, nickel, and alloyed products that are rolled, melted and/or finished ...
ATI Physical Therapy Reports Third Quarter 2024 Results
Prnewswire· 2024-11-04 21:05
BOLINGBROOK, Ill., Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today reported financial results for the third quarter ended September 30, 2024."Our consistent efforts to provide access to quality treatment for our patients underscores our strong operational performance in the third quarter," said Sharon Vitti, Chief Executive Officer of ATI. "We continue to see year-over-year ...
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
GlobeNewswire News Room· 2024-10-31 11:15
Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the November 6, 2024 shareholders meeting HALIFAX, Nova Scotia, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that the U.S ...
ATI's Earnings Miss Estimates in Q3, Revenues Increase Y/Y
ZACKS· 2024-10-30 12:10
ATI Inc. (ATI) recorded a third-quarter 2024 profit of $82.7 million or 57 cents per share compared with the year-ago quarter's $90.2 million or 62 cents. ATI posted adjusted earnings of 60 cents, down 6% from the yearago quarter figure of 64 cents. The bottom line missed the Zacks Consensus Estimate of 66 cents. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. The company's third-quarter net sales were $1,051.2 million, missing the Zacks Consensus Estimate of $1,127.4 million. Net sa ...
ATI(ATI) - 2024 Q3 - Earnings Call Transcript
2024-10-29 16:09
ATI Inc (NYSE:ATI) Q3 2024 Results Conference Call October 29, 2024 8:30 AM ET Company Participants David Weston - Vice President of Investor Relations Kim Fields - President, CEO & Director Don Newman - Executive VP of Finance & CFO Conference Call Participants Richard Safran - Seaport Research Partners Andre Madrid - BTIG David Strauss - Barclays Phil Gibbs - KeyBanc Capital Markets Timna Tanners - Wolfe Research Seth Seifman - JPMorgan Scott Deuschle - Deutsche Bank Operator Hello, everyone, and welcome ...
Allegheny Technologies (ATI) Q3 Earnings and Revenues Lag Estimates
ZACKS· 2024-10-29 13:46
Allegheny Technologies (ATI) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.09%. A quarter ago, it was expected that this maker of steel and specialty metals would post earnings of $0.58 per share when it actually produced earnings of $0.60, delivering a surprise of 3.45%.Over the ...
ATI(ATI) - 2024 Q3 - Quarterly Results
2024-10-29 11:36
NEWS RELEASE | --- | --- | |-------------------------------|-------| | | | | | | | Investor Contact: | | | David Weston | | | 412-394-2908 | | | david.weston@ATImaterials.com | | | --- | --- | |------------------------------------|-------| | | | | Media Contact: | | | Natalie Gillespie | | | 412-394-2850 | | | natalie.gillespie@ATImaterials.com | | ATI Inc. Corporate Headquarters 2021 McKinney Avenue Dallas, TX 75201 U.S.A. www.ATImaterials.com ATI Announces Third Quarter 2024 Results Ninth consecutive quar ...
ATI Announces Third Quarter 2024 Results
Prnewswire· 2024-10-29 11:30
Ninth consecutive quarter with sales in excess of $1 billion Q3 2024 sales of $1.05 billion Q3 2024 net income attributable to ATI of $82.7 million, or $0.57 per share Aerospace & defense represent 62% of Q3 2024 sales Full year 2024 guidance updated Non-GAAP Information* Q3 adjusted net income attributable to ATI of $85.9 million, or $0.60 per share Q3 2024 ATI adjusted EBITDA of $185.7 million, or 17.7% of sales, up 100 basis points sequentially DALLAS, Oct. 29, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) r ...
ATI Physical Therapy to Announce Third Quarter 2024 Financial Results
Prnewswire· 2024-10-21 16:00
BOLINGBROOK, Ill., Oct. 21, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. – ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United States, today announced that it will release third quarter 2024 financial results on Monday, November 4, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 5 p.m. ET on the same day. Conference Call Details Management will host a conference call at 5 p.m. Eastern ...
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
GlobeNewswire News Room· 2024-10-17 11:15
ATI-1701 provides full protection against lethal tularemia in animal models after one year Company to provide update on tularemia vaccine candidate ATI-1701 and present new data on efficacy Presentation scheduled for 3:15 pm ET on October 17, 2024 HALIFAX, Nova Scotia, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced t ...